Best Leukemia chemotherapy Doctors Worldwide — TOP 106

Dr. Zafer Gulbas founded and directs Turkey’s largest Bone Marrow Transplant Center at Anadolu Medical Center. He is a hematologist-oncologist specializing in complex blood cancers and clotting disorders. Dr. Gulbas trained at top global institutions, including MD Anderson and Fred Hutchinson in the USA. He performs autologous and allogeneic transplants for leukemia, lymphoma, and aplastic anemia.

• Achieved an 81% success rate for autologous bone marrow transplants.
• Supervised over 3,000 successful transplant procedures since 2010.
• Authored over 260 scientific publications with 5,000+ citations in hematology.
• Member of the European Hematology Association and American Hematology Association.

Dr. Eda Tanrikulu specializes in leukemia chemotherapy at Anadolu Medical Center, with extensive training and experience in medical oncology.

• Completed medical oncology training at Marmara University
• Ranked 3rd in Turkey's minor specialty exam
• Involved in international clinical studies
• Former head of medical oncology at Haydarpaşa Numune Training and Research Hospital

Prof. Christoph Zielinski leads Vienna's International Oncology Center and has shaped Austria's modern oncology for 44 years of experience.

• Founded the Comprehensive Cancer Center Vienna, integrating research and patient care
• Specializes in personalized leukemia therapies and immunotherapy approaches
• Former President of the Central European Cooperative Oncology Group (CECOG)
• Head of Austria's largest oncology department during his tenure

Head of the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – Dr. Merimsky specializes in complex sarcoma cases.

• Over 41 years of experience of experience in oncology
• Fellowship in soft tissue and bone sarcoma at Institut Gustave Roussy, Paris
• Member of ESMO Sarcoma Faculty and ASCO
• Published extensive research on tumor immunology

Head of Gastroenterology and Oncology at Academic Hospital Solingen – specializes in complex gastrointestinal and liver conditions.

• 34 years of experience in gastroenterology and oncology
• Author of 130+ publications on digestive diseases
• Specializes in malignant tumors of internal organs
• Member of European Society of Gastroenterology

Dr. Ram Ron brings extensive experience in leukemia chemotherapy at Sourasky Medical Center (Ichilov), known for its advanced cancer treatment facilities.

• Specializes in leukemia chemotherapy with a patient-centered approach
• Works at one of Israel's leading medical centers
• Committed to providing latest treatment protocols

300+ bone marrow and umbilical blood transplantations – Dr. Ronit El Hasid heads pediatric oncohematology at Sourasky Medical Center.

• Specializes in pediatric leukemia and transplant cases
• Published 50+ research papers in the field
• Member of American Association for Hematology
• Trained at City of Hope Hospital in Los Angeles

Dr. Ron Ram has performed several hundred stem cell transplants, showcasing his deep expertise in leukemia treatment at Sourasky Medical Center.

• Board-certified in Internal Medicine, Hematology, and Medical Oncology
• Published over 30 scientific articles on hematology and oncology
• Completed fellowship at New York Medical College, Westchester Medical Center
• Contributed a chapter to a medical textbook

Trained at Mayo Clinic – Dr. Sevindik brings advanced hematology expertise to Florence Nightingale Hospital.

• Specializes in leukemia chemotherapy with 12 years of experience of experience
• Published 18 articles in international peer-reviewed journals
• Presented research at 26 international conferences
• Works at Istanbul's leading hematology center

Dr. Li Ping, M.D., Ph.D., is Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital, Tongji University School of Medicine. She supervises doctoral and master's students and is an expert in hematologic malignancies.

She earned a Doctor of Medical Science from Nagoya University and completed postdoctoral research. She specializes in diagnosing and treating blood cancers. Her focus includes lymphoid malignancies—leukemias, lymphomas, and multiple myeloma. She treats patients with chemotherapy, hematopoietic stem cell transplantation, targeted therapy, and immunotherapy.

She is a pioneer in China in full-cycle CAR-T therapy for relapsed or refractory blood cancers. She leads and participates in national and international clinical trials. She serves on committees of professional societies, including the China Anti-Cancer Association. She also publishes and trains hematologists.

Dr. Amos Toren is a pediatric hemato-oncologist at Sheba Medical Center. He served as Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant Division. Dr. Toren holds a PhD in Human Genetics. He specializes in CAR T-cell therapy and bone marrow transplantation for children. Forbes Israel has recognized his expertise in hematology.

• Served as the Head of the Hematology Division at Tel Aviv University.
• Treats complex cases of leukemia, lymphoma, and rare pediatric cancers.
• Member of the American Society of Hematology and European Group for Blood and Marrow Transplantation.
• Collaborates on research with the NIH and St. Jude Children’s Research Hospital.

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.

• National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
• Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
• Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
• Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.

Prof. Bulent Eser brings 36 years of experience of hematology experience, specializing in leukemia treatment at Medical Park Antalya.

• Professor of Internal Medicine and Hematology since 2011
• Member of the European Group for Blood and Marrow Transplantation
• Specializes in leukemia chemotherapy and bone marrow transplantation
• Extensive research background in hematologic oncology

Prof. Bozkurt specializes in pediatric leukemia chemotherapy with 36 years of experience of focused expertise, currently serving as Clinical Director at Medical Park Bahcelievler Hospital.

• Trained in pediatric oncology at Dr. Sami Ulus Children's Hospital
• Completed observer programs at Harvard's Dana-Farber Cancer Institute
• Authored 40+ peer-reviewed articles on childhood cancers
• Vice Director of the Stem Cell Transplant Unit
• Member of European Bone Marrow Transplant Group

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Specialist in bone marrow transplantation – Dr. Rives Sola focuses on pediatric hematology at SJD Barcelona Children's Hospital.

• Children's hematologist with expertise in leukemia treatment
• Specializes in bone marrow transplantation procedures
• Works at a leading children's hospital in Barcelona

Dr. Graupera heads the Hematology Oncology Department at Sant Joan De Déu – one of Europe's top children's hospitals. His research focuses on pediatric cancer treatments.

• Award-winning pediatric oncologist with over 30 years of experience of experience
• Specializes in neuroblastomas, gliomas, and Ewing's sarcomas
• Trained at Memorial Sloan Kettering Cancer Center in the USA
• Developed a radiation-free treatment for spinal cord gliomas
• Published 70+ papers on pediatric cancer treatment